Diminished ovarian reserve describes a situation in which the ovary holds fewer remaining follicles than expected for a woman’s age, often accompanied by reduced levels of anti-Müllerian hormone, or AMH, in the blood and a disappointing yield of eggs during in vitro fertilization cycles. For the millions of women who face this diagnosis, treatment options remain limited largely because the underlying biology has stayed elusive. While chromosomes, genetics and blood flow to the ovary have all been implicated, researchers have increasingly turned their attention to the follicular microenvironment, the local soup of cells, fluids and signaling molecules in which each egg matures. It is here, the new study suggests, that a specific and potentially targetable form of cellular damage may be at work.

Ferroptosis is not ordinary cell death. Unlike apoptosis, the tidy, programmed dismantling of a cell, ferroptosis is a violent chemical cascade in which iron catalyzes the peroxidation of lipids in cell membranes, literally rusting them from within. The process is held in check by glutathione peroxidase 4, or GPX4, an enzyme that repairs oxidized lipids and is considered the central guardian against ferroptotic collapse. When GPX4 activity falters or oxidative pressure overwhelms it, membranes rupture and the cell dies in a way that floods surrounding tissue with inflammatory signals. Because the ovary is rich in iron and because developing follicles are metabolically demanding, ferroptosis has emerged as a compelling suspect in ovarian dysfunction, but its role in DOR had never been directly examined in human follicular cells until now.

The research team, led by Nadiye Koroglu of Acibadem Mehmet Ali Aydinlar University and Aylin Yaba of Yeditepe University Faculty of Medicine, recruited 81 women undergoing intracytoplasmic sperm injection, a form of IVF in which a single sperm is injected directly into an egg. Forty-six of the participants had diminished ovarian reserve while 35 had normal ovarian reserve, serving as controls. During egg retrieval, the researchers collected cumulus cells, the specialized support cells that cling to the oocyte and supply it with nutrients, metabolic intermediates and developmental signals. They also sampled follicular fluid, the liquid that bathes the growing egg inside its follicle. Because cumulus cells share a intimate metabolic dialogue with the oocyte, damage to these cells can translate directly into compromised egg quality, making them an ideal window into follicular health.

The molecular readouts were revealing. Using quantitative reverse transcription polymerase chain reaction, the team measured the expression of ferroptosis-associated genes and found that both GPX4 and EMP1 were significantly elevated in the cumulus cells of DOR patients compared with controls. At first glance, higher GPX4 might seem protective, but the authors interpret this upregulation as a compensatory response: the cells appear to be mounting a defense against rising lipid peroxidation pressure, a molecular cry for help that indicates the ferroptosis machinery has been activated. Consistent with this interpretation, measurements of reactive oxygen species, or ROS, in the follicular fluid showed significantly higher concentrations in the DOR group, confirming an oxidatively stressed environment around the developing eggs. Notably, ferritin levels, a marker of iron storage, did not differ between the groups, suggesting that the oxidative damage in DOR is not simply a story of iron overload but of a broader redox imbalance.

The oocytes themselves told a parallel story of energetic decline. Using MitoTracker fluorescence, a dye that accumulates in active mitochondria in proportion to the electrical charge across their membranes, the researchers assessed germinal vesicle-stage oocytes, the immature eggs whose nuclear material is still enclosed. In eggs from women with DOR, mitochondrial membrane potential-related fluorescence was significantly reduced. This matters because the mitochondrial membrane potential is the engine of cellular energy production; a weakened potential means less ATP generation, poorer calcium handling and impaired completion of meiosis, all of which compromise the egg’s ability to be fertilized and develop into a viable embryo. Mitochondrial dysfunction has long been associated with reproductive aging, and this study provides direct evidence that it accompanies diminished ovarian reserve in human eggs retrieved during treatment.

Intriguingly, the study also probed the Hippo signaling pathway, an ancient growth-control network whose components, including MST1, LATS2 and YAP1, regulate organ size, cell proliferation and follicle activation. At the level of gene transcription, the Hippo pathway appeared unchanged: messenger RNA levels of MST1, LATS2 and YAP1 in cumulus cells did not differ between the DOR and control groups, whether measured directly or after the researchers manipulated ferroptosis in laboratory culture. But when the team turned to immunofluorescence staining to visualize the proteins themselves, a different picture emerged. Cumulus cells from DOR patients showed a significantly increased nuclear ratio of phosphorylated YAP to total YAP, along with elevated phosphorylated LATS1/2, while phosphorylated MST1 trended downward. These post-translational modifications indicate that DOR may modulate Hippo and YAP signaling not by changing how much of the pathway is produced, but by chemically altering the proteins after they are made, shifting their location and activity within the cell.

The technical achievement of the study lies in this multi-layered approach. By combining gene expression analysis, protein localization through immunofluorescence with DAPI-stained nuclei, biochemical assays of ROS and ferritin in follicular fluid, and live-cell fluorescence imaging of oocyte mitochondria, the researchers built a converging line of evidence from independent angles. Each measurement on its own could be dismissed as noise, but together they sketch a coherent mechanism: oxidative stress rises in the follicular fluid of DOR patients, cumulus cells respond by upregulating ferroptosis-defense genes, the Hippo pathway is re-tuned at the protein level, and the oocytes they support suffer measurable mitochondrial weakening. The slight, non-significant rise in intracellular ROS within cumulus cells themselves hints that the cells are under strain but have not yet crossed the threshold of overt damage, a snapshot of a process caught in progress.

The clinical implications are tantalizing, though the authors are careful to frame their findings as a foundation for further work rather than a treatment blueprint. If ferroptosis-associated oxidative stress genuinely contributes to the decline of egg quality in DOR, then interventions that shore up antioxidant defenses, such as GPX4-supporting compounds, iron chelators or lipid peroxidation inhibitors, could in principle protect the follicular microenvironment. The post-translational changes in Hippo signaling add a second potential lever, since YAP activity is known to influence follicle growth and activation, and pharmacological modulation of this pathway is an active area of reproductive research. Before any of that becomes reality, however, the findings will need to be replicated in larger and more diverse cohorts, and the causal direction will need to be established: whether ferroptotic stress drives diminished ovarian reserve or is merely a consequence of it remains the pivotal open question.

What the study undeniably delivers is a molecular portrait of a condition that has long been defined only by numbers, fewer follicles, lower AMH, fewer eggs retrieved. Behind those numbers, the research reveals a follicular ecosystem under oxidative siege, its support cells activating ancient cell-death defenses and its eggs running low on mitochondrial power. Part of this work was presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology in Paris in 2025, and the full study, funded by the Health Institutes of Turkey, is now open access, allowing clinicians and researchers worldwide to scrutinize the data. For women facing a DOR diagnosis, the research does not yet offer a therapy, but it does offer something arguably just as valuable: a specific, testable biological mechanism, and with it, a genuine target for the next generation of fertility research.

Subject of Research: Ferroptosis-associated oxidative stress and mitochondrial alterations in the follicles of women with diminished ovarian reserve

Article Title: Ferroptosis-associated oxidative stress in cumulus cells and mitochondrial alterations in oocytes of women with diminished ovarian reserve

Article References: Koroglu, N., Dogan, S., Aydin, T., Bican, G., Kilic, E., & Yaba, A. (2026). Ferroptosis-associated oxidative stress in cumulus cells and mitochondrial alterations in oocytes of women with diminished ovarian reserve. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02265-w

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02265-w

Keywords: ferroptosis, diminished ovarian reserve, cumulus cells, oxidative stress, oocyte, mitochondria, Hippo signalling pathway, GPX4, YAP, reactive oxygen species, fertility, IVF

The research team set out to address a persistent gap in reproductive virology. Viral infections in the female reproductive tract are well known to pose risks to fertility, and previous studies in mice have shown that viral infection of the ovaries can compromise pregnancy. Yet the specific impact of viruses on ovulated oocytes—the mature eggs that have just been released from the ovary—and the role played by the surrounding cumulus cells remained poorly understood. Cumulus cells form a layered, cloud-like structure called the cumulus oophorus around the oocyte, and together the egg and its companion cells are known as the cumulus–oocyte complex, or COC. This intimate relationship is metabolically essential: the oocyte depends on cumulus cells for nutrients, signaling molecules, and developmental cues throughout its maturation. What Sasaki and Kawahara wanted to know was whether this dependency could become a liability during a viral attack.

To model the situation, the researchers used vesicular stomatitis virus, or VSV, a bullet-shaped RNA virus that is a standard laboratory tool for studying antiviral immunity. VSV enters cells through clathrin-dependent endocytosis and replicates rapidly in the cytoplasm, making it a reliable trigger of the innate immune pathways that cells use to detect RNA viruses. The team exposed mouse cumulus–oocyte complexes to the virus and then assessed how the cells responded at the level of gene expression, using quantitative real-time PCR to measure antiviral transcripts. In parallel, they tracked developmental outcomes by fertilizing the exposed oocytes in vitro and counting how many progressed through cleavage divisions and on to the blastocyst stage, the last step before implantation.

The gene expression analysis revealed a striking asymmetry between the two cell types in the complex. Ovulated oocytes did express retinoic acid-inducible gene-I, known as RIG-I, which is the cytosolic receptor that detects RNA viruses inside infected cells. But the oocytes lacked expression of two other key sensors of the RIG-I family: melanoma differentiation-associated gene 5, or MDA5, and laboratory of genetics and physiology 2, or LGP2. These helicase genes were present in the cumulus cells. The finding matters because the RIG-I family of DExD/H-box helicases forms the front line of intracellular RNA virus detection, with RIG-I and MDA5 recognizing different classes of viral RNA and LGP2 acting as a regulatory partner that fine-tunes their activity. The differential expression suggests that the oocyte’s antiviral surveillance toolkit is incomplete, and that its defenses may rely heavily on the completeness of the cumulus cells’ immune machinery.

When intact cumulus–oocyte complexes were exposed to VSV, the consequences for development were clear. The virus significantly impaired preimplantation development, reducing both the rate at which fertilized eggs underwent cleavage and the rate at which embryos formed blastocysts. Yet when the researchers looked for evidence of actual viral infection inside the oocytes and early embryos, they found none. The authors attribute this protection to the zona pellucida, the glycoprotein shell that surrounds the oocyte and early embryo and acts as a physical barrier. This result reframes the problem: the damage to development occurs without the virus ever setting foot inside the cell it ultimately harms.

Several follow-up experiments cemented the indirect mechanism. First, when the researchers stripped the cumulus cells away and exposed denuded oocytes directly to VSV, the oocytes neither induced antiviral gene expression nor showed developmental defects. On their own, the eggs simply did not respond to the virus. Second, and most tellingly, when uninfected oocytes were co-cultured with VSV-infected cumulus cells, their development was impaired—demonstrating that the mere presence of infected neighbors, with no virus reaching the oocyte, was sufficient to cause the damage. The virus, in effect, converted the egg’s own nurse cells into a source of developmental toxicity.

The molecular signature of the infected cumulus cells explained why. The infected cells exhibited a robust antiviral response, with significant upregulation of RIG-I itself, interferon-beta, interleukin-6, and tumor necrosis factor-alpha. Interferon-beta is the classic first-responder signal of the antiviral state, while interleukin-6 and tumor necrosis factor-alpha are inflammatory cytokines that can act on neighboring cells. Crucially, the researchers found that oocytes and zygotes express the receptor subunits for interleukin-6, encoded by the genes Il6ra and Gp130. This means the egg is structurally equipped to receive and respond to IL-6 signals arriving from its surroundings. The interleukin-6 pathway is already known to play roles in preimplantation embryos, where the IL-6 family cytokine leukemia inhibitory factor is essential for implantation, and the IL-6/STAT3 axis has been linked to anti-apoptotic signaling in mouse embryos. The new data identify IL-6 as a candidate mediator of the developmental impairment caused by infected cumulus cells.

The study’s authors frame the findings as revealing both the protective and the vulnerable nature of the cumulus–oocyte complex during viral challenge. The cumulus cells act as a shield: their complete antiviral sensor repertoire allows them to detect and respond to the virus, and the physical barrier of the zona pellucida keeps the virus out of the oocyte. But the same activation that defends the complex also floods the perivitelline environment with inflammatory cytokines, and the oocyte, which lacks its own full complement of viral sensors, appears susceptible to the paracrine consequences. The work thus provides a mechanistic account of how the maternal inflammatory microenvironment can influence early embryonic success, even in the absence of direct infection of the embryo itself.

The implications extend to a broader literature on viral infection and fertility. Hepatitis E virus has been shown to replicate in the ovary and promote oocyte apoptosis in rabbits, and Zika virus has been shown to cause acute infection and inflammation in the mouse ovary, with sexual transmission routes documented in mouse models. Herpes simplex virus type 2 sheds asymptomatically in the human female genital tract, and viral infection of the ovaries has been shown to compromise pregnancy while also revealing innate immune mechanisms that protect fertility. The new study adds a distinct mechanism to this list: not direct ovarian infection, and not viral tropism for the gamete, but the transformation of the egg’s own supporting cells into cytokine factories that compromise its developmental competence. This pathway could be relevant to unexplained fertility deficits associated with systemic or reproductive tract viral illness.

For the assisted reproduction field, the results suggest that the health of cumulus cells is not merely a marker of oocyte quality but an active determinant of embryo outcomes under immune challenge. The work was supported by JSPS KAKENHI grants 24K09199, awarded to Sasaki, and 24K01902, awarded to Kawahara, and all animal experiments were approved by the Regulatory Committee for the Care and Use of Animals of Hokkaido University. The authors note that the datasets supporting the developmental rate findings are available in the supplementary materials, with other data available from the corresponding author on reasonable request. Future work, the study implies, will need to test whether blocking interleukin-6 signaling during viral illness can rescue the developmental potential of exposed oocytes, and whether the same paracrine mechanism operates in other species, including humans—questions that could shape how fertility preservation is approached in patients confronting acute viral infections of the reproductive tract.

Subject of Research: Antiviral responses of mouse cumulus–oocyte complexes and indirect viral impairment of oocyte developmental competence via cumulus cell inflammatory signaling.

Article Title: Viral Infection of Cumulus Cells Impairs the Developmental Competence of Ovulated Mouse Oocytes

Article References: Sasaki, K., & Kawahara, M. (2026). Viral Infection of Cumulus Cells Impairs the Developmental Competence of Ovulated Mouse Oocytes. Biochemical Genetics. https://doi.org/10.1007/s10528-026-11449-4

Image Credits: AI Generated

DOI: 10.1007/s10528-026-11449-4

Keywords: oocyte, cumulus cells, vesicular stomatitis virus, antiviral response, RIG-I, interleukin-6, zona pellucida, fertility, preimplantation embryo, paracrine signaling, viral infection, reproductive immunology